ClinicalTrials.Veeva

Menu

Sellar Masses: Clinical and Imaging Features With Correlation to Histopathology and Surgical Approach

A

Arab Board of Neurosurgery

Status

Completed

Conditions

Sellar Mass
Pituitray Tumor

Treatments

Procedure: Craniectomy

Study type

Observational

Funder types

Other

Identifiers

NCT07633860
TMGH-2026-Ethics-30

Details and patient eligibility

About

The goal of this observational study is to learn about the clinical spectrum of sellar masses, aiming to understand the correlation between the imaging features and the future surgical approach and histopathology results.

The main question it aims to answer is:

Does being both LMIC and conflict country change the global data!? Participants were included during a period of 3 years in a governmental hospital TMGH.

Enrollment

49 patients

Sex

All

Ages

11 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Radiologically confirmed sellar, suprasellar, or parasellar mass.
  • Surgical candidacy
  • Histopathological confirmation
  • Age ≥ 11 year

Exclusion criteria

  • Incomplete diagnostics
  • Recurrent disease
  • Primary metastatic disease.

Trial design

49 participants in 1 patient group

Patients with confirmed sellar masses
Description:
Patients withe age of 11 to 65, who was diagnosed with sellar mass using MRI, and get treated surgically
Treatment:
Procedure: Craniectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems